Elizabeth E. Reed, SVP, GC & CORPORATE SECRETARY at Travere Therapeutics, Inc. (TVTX), sold 4,764 shares at $8.86 ($41K) on 2024-02-01, disclosed to the SEC on 2024-02-02.
Scheduled sale ($41k) by SVP, GC & CORPORATE SECRETARY under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.53 | 2,174 | $19K | 44.7% |
| 2 | $8.86 | 2,590 | $23K | 55.3% |
| Total | $8.71 avg | 4,764 | $41K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.1M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |